Financial
Auriga Partnershttp://www.aurigapartners.comAuriga Partners is an independent Venture Capital firm located in Paris which invests in digital and life-sciences sectors. The company targets innovative projects with high potential from the earliest stages of development to the global commercial expansion. Through 4 generations of funds, Auriga Partners manages more than €350m and provides its portfolio companies with its expertise in structuring management teams, building a robust organization and closing strategic global partnerships. The team supported dozens of successful companies with an experience of both M&A and IPOs. These companies include: Amoeba (EuroNext), Availpro (Accor), Codenvy (RedHat), Ekinops (EuroNext), Erytech (EuroNext), EVE (Synopsys), Genocea (Nasdaq), Median (AlterNext), Miliboo (AlterNext), Neolane (Adobe), Novagali (Santen), Oxand (Latour), Supersonic Imagine (EuroNext), TxCell (EuroNext) et Wallix (AlterNext).
|
|
Bpifrancewww.bpifrance.fr
Bpifrance, a subsidiary of Caisse des Dépôts and the French State, is a trusted partner of entrepreneurs which provides companies with credit, collateral and equity financing support - from start up through to stock exchange listing. In partnership with Business France, Bpifrance also provides guidance and enhanced support services for innovation, external growth, and export. Bpifrance offers companies a range of financing for each key stage in their development, and an offer adapted to regional particularities. With 47 regional offices (90% of decisions are made regionally), Bpifrance offers entrepreneurs a tool for economic competitiveness. Bpifrance works in support of the public policies pursued nationally and regionally by the French government, to meet three objectives: support the growth of businesses, prepare for future competitiveness, contribute to the development of an ecosystem that encourages entrepreneurship. With Bpifrance, companies benefit from a strong and effective local contact able to meet all their financial, innovation and investment needs.
|
|
Edmond de Rothschild Investment Partnershttp://www.edrip.fr
PEdmond de Rothschild Investment Partners is a leader in investment in privately owned companies. Its strategies benefit the companies in which it
|
|
Merieux Développementhttp://www.merieux-developpement.comMérieux Développement is specialized in venture capital and growth equity transactions in the healthcare and nutrition sectors. Mérieux Développement supports entrepreneurs and companies with products or services offering worldwide innovation to the healthcare market. Mérieux Développement brings its expertise and international network to enable entrepreneurs to disrupt and create new market opportunities. Mérieux Développement is an affiliate of Institut Mérieux, which employs approximately 17,000 employees worldwide, with consolidated revenues exceeding 2.5 billion Euros in 2016.
|
|
NBGI Ventureshttp://www.nbgiventures.comNBGI Ventures manages the EUR 60m NBG Technology LP, which invests in promising technology-centric companies in Europe, including Greece. The NBG Technology LP is an independent fund, based in the UK and backed by three prominent financial institutions, including the European Investment Fund (EIF).
Operating from its offices in London and Athens, NBGI Ventures is managed by a dedicated team of professionals with substantial experience in both the technology and financial sectors.
|
|
Omnes Capitalwww.omnescapital.comOmnes Capital is a major player in private equity and infrastructure. With €3.6 billion in assets under management, Omnes Capital provides companies with the capital needed to finance their growth and with key expertise in a number of areas: Buyout & Growth Capital, Venture Capital, and Infrastructure. Omnes Capital was part of the Crédit Agricole group until March 2012. The firm is now owned by its employees. Omnes Capital is a signatory to the United Nations Principles for Responsible Investment (PRI).
|
|
